Regeneron Pharmaceuticals, Inc.

Grantham, Mayo, Van Otterloo & Co. LLC REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

56,704

Value ($000)

43,768

Weight

0.1%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	43,768	0.1%	56,704	12/31/2025
2025 Q3	11/13/2025	34,565	0.1%	61,474	9/30/2025
2025 Q2	8/13/2025	34,274	0.1%	65,283	6/30/2025
2025 Q1	5/14/2025	52,850	0.2%	83,330	3/31/2025
2024 Q4	2/13/2025	44,862	0.1%	62,979	12/31/2024
2024 Q3	11/13/2024	54,661	0.2%	51,997	9/30/2024
2024 Q2	8/13/2024	60,186	0.2%	57,264	6/30/2024
2024 Q1	5/14/2024	55,690	0.2%	57,860	3/31/2024
2023 Q4	2/13/2024	58,933	0.3%	67,100	12/31/2023
2023 Q3	11/13/2023	47,682	0.2%	57,940	9/30/2023
2023 Q2	8/14/2023	38,014	0.2%	52,904	6/30/2023
2023 Q1	5/12/2023	55,169	0.3%	67,142	3/31/2023
2022 Q4	2/13/2023	51,328	0.3%	71,142	12/31/2022
2022 Q3	11/10/2022	37,199	0.2%	54,000	9/30/2022
2022 Q2	8/12/2022	33,340	0.2%	56,400	6/30/2022
2022 Q1	5/13/2022	33,454	0.2%	47,900	3/31/2022
2021 Q4	2/11/2022	29,934	0.1%	47,400	12/31/2021
2021 Q3	11/12/2021	29,835	0.1%	49,300	9/30/2021
2021 Q2	8/12/2021	27,089	0.1%	48,500	6/30/2021
2021 Q1	5/13/2021	19,683	0.1%	41,600	3/31/2021
2020 Q4	2/12/2021	13,602	0.1%	28,156	12/31/2020
2020 Q3	11/13/2020	255	0.0%	456	9/30/2020
2020 Q2	8/13/2020	284	0.0%	456	6/30/2020